- Home
- E vs CAH Comparison
E vs CAH Comparison
Compare E & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | E | CAH |
|---|---|---|
| Founded | 1953 | 1979 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Other Pharmaceuticals |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.0B | 49.4B |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | E | CAH |
|---|---|---|
| Price | $38.93 | $213.15 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 12 |
| Target Price | N/A | ★ $204.75 |
| AVG Volume (30 Days) | 273.5K | ★ 1.8M |
| Earning Date | 02-26-2026 | 02-05-2026 |
| Dividend Yield | ★ 4.16% | 0.98% |
| EPS Growth | 6.01 | ★ 27.25 |
| EPS | 0.96 | ★ 6.63 |
| Revenue | $101,555,790,226.00 | ★ $234,310,000,000.00 |
| Revenue This Year | N/A | $16.60 |
| Revenue Next Year | N/A | $8.26 |
| P/E Ratio | ★ $18.89 | $31.43 |
| Revenue Growth | N/A | ★ 4.39 |
| 52 Week Low | $24.65 | $119.25 |
| 52 Week High | $39.41 | $214.93 |
Technical Indicators
Market Signals| Indicator | E | CAH |
|---|---|---|
| Relative Strength Index (RSI) | 60.78 | 66.77 |
| Support Level | $36.62 | $199.95 |
| Resistance Level | $39.41 | $211.77 |
| Average True Range (ATR) | 0.52 | 3.89 |
| MACD | 0.05 | 0.09 |
| Stochastic Oscillator | 86.02 | 97.37 |
Price Performance
Historical ComparisonAbout E ENI S.p.A.
Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2024, the company produced 0.8 million barrels of liquids and 4.8 billion cubic feet of natural gas per day. At end-2024, Eni held reserves of 6.5 billion barrels of oil equivalent, 46% of which are liquids. The Italian government owns a 30.5% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity called Plenitude, which it will likely list publicly at some point.
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.